Medium materiality6/10
Insmed price target lowered to $198 from $212 at Roth Capital
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Roth Capital lowers INSM target to $198; posted price is $125.30.
- Target $198; price $125.30
Key facts
- 01
Target: $198
- 02
Posted price: $125.3
- 03
Analyst firm: Roth Capital
- 04
Analyst: Adam Walsh
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.